Howmedica TS Universal Baseplate Finishing Tray Recall Z-0164-2027 Case Study

Why this case matters

Device recalls are usually read as a single event: a firm identifies a problem, FDA classifies it, product is returned, and the matter closes. The record behind the Howmedica Osteonics TS Universal Baseplate Finishing Tray recall, designated Z-0164-2027, is more useful than that reading allows, because the visible trace of it in the material available here is thin. That thinness is itself the lesson. Readers who follow medical-device litigation often arrive at a recall number expecting a narrative of harm, a set of affected patients, and a resolution. Sometimes the record supplies none of those things, and the honest analysis is an account of what the regulator published and what it left unstated.

The case also matters because of how recall information circulates. A recall number can travel through secondary sources, trade summaries and commentary while the underlying regulatory entry remains the only primary evidence. When the primary evidence is sparse on a specific point (affected units, injury reports, the clinical outcome of any exposure) secondary accounts tend to fill the gap, often without saying so. A retrospective reading is an opportunity to separate what the classification action actually establishes from what has been assumed around it.

For litigation purposes the distinction has practical weight. A recall classification is a regulatory characterization of a hazard and its potential consequences. It is not a finding of negligence, not an adjudication of causation in any individual patient, and not a court order. Matters that follow a recall, whether individual product-liability suits or consolidated proceedings, are built from separate evidence about a specific device, a specific patient and a specific injury. The recall entry may be relevant to that evidence. It does not substitute for it.

The official record

The subject of this analysis is the FDA record for the Howmedica Osteonics TS Universal Baseplate Finishing Tray recall, Z-0164-2027, described as a Class II action concerning sterilization dry time and residual moisture. That description (the recall number, the firm, the product, the class and the stated reason) is the extent of what the supplied documents establish about this particular recall. The documents provided for this case study do not include the recall entry itself in a form that supplies additional fields.

What the supplied material does contain is context on how FDA device-recall data is published and how it should be weighed. The openFDA device enforcement dataset carries a standing disclaimer stating that the agency makes every effort to keep the data accurate but that results should be assumed unvalidated, and warning against relying on the service to make decisions about medical care. The same disclaimer addresses the consequence that device recalls often turn on: where a sterile barrier is compromised, patients and users may be exposed to microbial contamination, and potential health consequences may range from no injury to localized infection to, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention or hospitalization.

That passage is general guidance attached to the dataset, not a finding about the TS Universal Baseplate Finishing Tray. It is nonetheless the most directly relevant regulatory language in the record, because the stated reason for this recall (sterilization dry time and residual moisture) concerns the conditions under which a sterile barrier is maintained. The documents do not state that any barrier failure occurred in this recall, and they do not state that any patient was exposed.

The remaining documents are reference material rather than case evidence. They include the FDA 510(k) premarket notification database page, which describes a 510(k) as a submission demonstrating that a device to be marketed is as safe and effective, and substantially equivalent, to a legally marketed device not subject to premarket approval. They include the Federal Register’s agency page for FDA, which carries the standing notice that the prototype edition is not an official legal edition and does not replace the official print or govinfo version. They include the federal judiciary’s statistics portal and unrelated openFDA enforcement records for food and for other device firms. None of these speaks to Z-0164-2027.

What the documents establish

Four points can be stated with confidence, and no more.

First, the recall exists as a classified regulatory action. The record identifies it as Z-0164-2027, a Class II recall by Howmedica Osteonics concerning the TS Universal Baseplate Finishing Tray, with sterilization dry time and residual moisture given as the reason. Classification as Class II places the action in the middle tier of FDA’s recall hierarchy, a designation concerned with products that may cause temporary or medically reversible harm, or where the probability of serious harm is remote. The documents supplied here do not set out the classification rationale in the agency’s own words, so the designation should be cited as a classification and not expanded beyond it.

Second, the documents do not establish any injury. There is no report of patient harm, no adverse-event filing, no infection cluster and no clinical finding tied to this recall anywhere in the supplied material. The dataset disclaimer describes a range of possible consequences of a compromised sterile barrier in general terms. A range of possible consequences is not a record of an occurrence, and the difference matters in any later proceeding.

Third, the documents do not establish a quantity, a distribution scope or a date. The record does not state how many units were affected, where they were distributed, when the recall was initiated, when it was classified, or whether it has been terminated. Other entries in the supplied openFDA enforcement sample carry fields for product quantity, distribution pattern, initiation date, center classification date and termination date, which shows that such fields exist in the dataset generally. Their absence here means the case-specific values are not in evidence, not that they are zero or unknown to the agency.

Fourth, the documents do not establish any litigation. There is no complaint, docket number, court, settlement, verdict or judicial order in the supplied material. Nothing in the record indicates that a claim has been filed arising from this recall, and nothing indicates that one has not been.

How a claim of this kind is assessed

Matters that follow a device recall are assessed through a sequence of questions, and each is answered with evidence independent of the recall classification.

The threshold question is product identification. A plaintiff in a device matter has to connect the device at issue to the plaintiff, typically through lot or serial information, operative records and the implant or explant documentation held by the treating facility. A recall number identifies a product line and a problem. It does not identify which units a particular patient received, and the documents here do not supply any unit-level information at all.

The second question is the defect or condition itself and its relationship to the harm alleged. Where a recall concerns sterilization and moisture, the analytical work tends to focus on whether the packaging condition described actually obtained in the unit at issue, whether the sterile barrier was breached, and whether any breach is causally connected to a clinical event. The dataset disclaimer’s range (from no injury through localized infection to less commonly more serious infection) illustrates why this inquiry is fact-specific: the same packaging condition may produce no clinical consequence in one instance and a treated infection in another.

The third question is the regulatory status of the recall and what it does and does not prove. A Class II classification is the agency’s characterization of hazard and probability. It is not a finding that any particular unit was nonconforming, and it does not establish causation for any individual. Courts generally treat recall evidence as one part of a larger record, to be weighed alongside design and manufacturing evidence, directions for use, and clinical records. The documents here do not describe how any court has treated this particular recall, because they contain no court material.

The fourth question is procedural posture and timing. Device claims are subject to limitations periods, to preemption arguments in some categories of device, and to the ordinary requirements of expert disclosure on both defect and causation. None of these is addressed in the supplied documents, and none can be evaluated for this recall on the present record.

What to check before relying on any figure

The first check is whether a number attributed to this recall appears in a primary regulatory source. The record supplied here does not state a figure for units affected, units distributed, injuries, infections, revisions, or any monetary amount. Any such figure encountered elsewhere should be traced to an agency entry or a filed document before it is repeated. Where the record is silent, the correct formulation is that the filings do not disclose a figure.

The second check is the status of the recall entry at the time of reading. FDA recall data is updated and terminated over time, and the openFDA disclaimer expressly frames the dataset as unvalidated. A retrieval of the same recall on a different date may show fields that were absent earlier. For that reason a recall should be cited with the retrieval date and the dataset named, not as a static fact.

The third check is the difference between the openFDA dataset and FDA’s official publications. The Federal Register material in the record carries its own warning that the prototype edition is not an official legal edition and does not replace the official version on govinfo. The same discipline applies here: openFDA is a convenience layer over agency data, useful for locating a record, but not itself an official legal edition of anything.

The fourth check is classification language. Class II should be reported as Class II, with the agency’s stated reason quoted or closely paraphrased, and without importing the consequences of a Class I action or the finality of a court judgment. The recall number Z-0164-2027 identifies the action. It does not describe an outcome, and no outcome should be inferred from it.

The fifth check is the boundary between regulatory and civil proceedings. A reader asking how this case resolved should be told plainly that the record shows a classified recall and nothing further: no injury finding, no quantity, no distribution scope, no litigation, no settlement and no verdict appear in the documents. That is a complete answer to the question the record can answer, and it is a more accurate one than any narrative assembled to fill the remaining space.

Sources

• U.S. Food and Drug Administration
• U.S. Food and Drug Administration
• U.S. Food and Drug Administration
• 510(k) Premarket Notification
• Federal Register :: Agencies - Food and Drug Administration
• U.S. Food and Drug Administration
• Data & News